• A Hybrid Conference and Internet Event
• Sponsored by Asia Pacific Healthcare Industry Compliance Team
• Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Pharmaceutical Compliance Forum (PCF)
• September 21 - 23, 2016
• Shangri-La Hotel, Singapore
• www.AsianPharmaCongress.com

SINGAPORE -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 23, 2016: The Sixth Asia Pacific Pharmaceutical and Medical Device Compliance Congress, www.AsianPharmaCongress.com, will be held September 21 - 23, 2016, at the Shangri-La Hotel in Singapore. Registrants may attend the event in person or online (live webcast and archived for 6 months).

KEYNOTE SPEAKERS

Charles Cain, JD Deputy Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC Graeme Gunn Legal Analyst and Manager China Outreach, Anti-Corruption Division, OECD; Former Senior Legal Officer, Attorney-General's Department, Australia, Paris, France Ben Morgan Joint Head of Bribery and Corruption, UK Serious Fraud Office, London, UK Sophie Peresson, LLM, MA Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, London, UK Jean-Christophe Pointeau, CEDEP INSEAD General Manager Pharma, Sanofi China, Vice Chairman, RDPAC-China, Former General Manager, BMS China, Former General Manager, BMS Poland, Shanghai, China Neill Stansbury, Esq. Co-founder and Director of the Global Infrastructure Anti-Corruption Centre, Chair, International Organization for Standardization Anti-Bribery Project Committee, Vice Chair, Anti-corruption Standing Committee, World Federation of Engineering Organization, Buckinghamshire, UK

KEYNOTE GLOBAL CHIEF COMPLIANCE OFFICER ROUNDTABLE

Dante Beccaria Senior Vice President, Global Ethics & Business Integrity, Sanofi, Vice Chair, Code Committee Network, IFPMA, Paris, France Anne Nielsen, JD, LLM Senior Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Chair, Code Committee Network, IFPMA, New York, NY, USA Lori Queisser Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Former Sr. VP Global Compliance and Business Practices, Schering-Plough, Former Vice President, Chief Compliance Officer, Eli Lilly, Philadelphia, PA, USA Caroline West Global Chief Compliance Officer, Olympus Corporation; Former Senior Vice President, Chief Compliance and Risk Officer, Shire, Philadelphia, PA, USA Ted Acosta, Esq. Americas Vice Chair, Risk Management and Global Leader, Life Sciences, Fraud Investigation and Dispute Services, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France (Moderator)

FEATURING PRECONFERENCE SESSIONS Compliance 101 Workshop Use of Analytics to Manage Risks and Detect Fraud PLENARY SESSIONS C-Suite Keynote Address Global Compliance Officer Roundtable Transparency International Keynote UK Serious Fraud Office Update US Securities and Exchange Commission Update The ISO 37001 Anti-Bribery Management Systems Standard Asia Pac Regional Regulatory and Enforcement Roundtable Asia Pac Compliance Code and APEC Principles Updates Optimizing the Relationship with Third Parties Best Practices in Medical Affairs Compliance Life Sciences Compliance Challenge: Moving from Cost to Value Roundtable on Creating an Ethical Culture AND MINI SUMMITS China, Hong Kong and Taiwan Compliance Roundtable India Compliance Roundtable Innovation in Compliance Patient Support Programs Compliance Issues Transactions, Partnerships and M&A Compliance Issues Asia Pac Medical Device Compliance Roundtable Promotional and Incentive Programs Compliance Issues Asia Pac Transparency and Disclosure Updates Research and Development Compliance Issues ASIA PACIFIC PHARMA CONGRESS IS

FEATURED FACULTY

Dr. Milind Antani, MBBS, LLB Partner in charge-Pharma & Healthcare Practice, Nishith Desai Associates, Mumbai, India Dennis K. Barnes, JD, CPA Vice President, Compliance and Risk Management, Global Compliance Officer, PAREXEL International Corp., Waltham, MA, USA Eric Carlson, Esq. Partner, Covington & Burling LLP, Contributing Editor, FCPA Blog, Shanghai, China Stacy Chai Director, Fraud Investigation & Dispute Services, EY, Singapore Sabrina S. K. Chan, MA, JD Executive Director, The Hong Kong Association of the Pharmaceutical Industry (HKAPI), Hong Kong Tom Chan, JD, LLM Head of Legal, Greater China, Takeda (China) Holdings Co. Ltd, Shanghai, China Chi Chen, MS Partner, EY, Shanghai, China Eugene Chen, Esq. Partner, Beijing Office, Hogan Lovells International LLP, Shanghai, China Yoo-Kyung (Karen) Choi, JD, LLM Japan and Korea Compliance Lead, Pfizer, Seoul, Korea Hwa-Soo Chung, Esq. Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea Mike Dethick Managing Director, R&D-Based Pharmaceutical Association Committee, Beijing, China Adam Dryburgh LLB, Dip LP, LLM Associate, White Collar and Fraud Group, Hogan Lovells, Singapore Michael Dusseau Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, New York, NY, USA Marc Eigner, MS, MBA Senior Partner, Co-Founder and Head of the Technology Solutions, Polaris Solutions, New York, NY, USA Karen Eryou Senior Director, Corporate Compliance APAC, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Shanghai, China Giuseppe Falbo Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc., Singapore Don Ferrin, PhD Professor of Organisational Behaviour and Human Resources, Singapore Management University, Singapore Andrew Frye, MBA Global Head, Business Unit Healthcare, Member of Group Management, DKSH, Bangkok, Thailand Ramon Ghosh Director, CFI, Control Risks, Singapore Gary Giampetruzzi, Esq. Partner, Paul Hastings; Former Vice President and Assistant General Counsel and Head, Government Investigations, Pfizer Inc., Washington, DC, USA Priyanka Sharma Goswami, LLB, BCL Advocate & Partner, Quad Law Associates, Former an Associate Counsel, Offices of Additional Solicitor General of India, New Delhi, India Mohit Grover Executive Director, Risk Consulting, Deloitte, Former Regional CIO, Astra Zeneca Asia Pacific, Singapore Andrew Ho Head of Ethics and Business Integrity, Australia and New Zealand, Sanofi, Former Compliance Associate, Novartis, Macquarie Park NSW, Australia David Hodgson Partner and Audit Advisory Global Lead, Deloitte, London, UK Ewa Holker, JD Head of Legal & Compliance, Asia Pacific, Ferring, Singapore Rajiv Joshi, ICAI, ISACA, CIA, CFE Partner, Fraud Investigation & Dispute Services, EY, Mumbai, India Casey Kah Partner, EY, Shanghai, China Jasmine Karimi, LLM Senior Director and Counsel, APAC, Illumina, Former President, Hong Kong Corporate Counsel Association, Singapore Reuben Khoo, MBA Managing Partner, FIDS ASEAN, Head of Forensic Technology & Discovery Services Asia Pacific, EY, Singapore Christopher E. Knight, JD Senior Executive Advisor, Pharmaceutical Research and Manufacturers Association Thailand (PReMA), Chief Executive Officer, Everett Knight (Asia Pacific) Pte Ltd., Singapore Sarah Kochling Managing Principal, Blossom Consultancy Ltd., Shanghai, China Katsumi Kojima Head of Ethics & Business Integrity-Japan, Sanofi Japan Group, Tokyo, Japan Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA Benjamin Kwak, JD Vice President, Compliance Officer and Senior Legal Counsel (Asia Pacific), Zimmer Biomet, Singapore Henry J. Li Legal Director and General Counsel, R&D Based Pharmaceutical Association Committee, Beijing, China Lei Li, LLM Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China Abdul Luheshi, MBA Director, Life Sciences Regulatory Compliance, KPMG, Former Vice President, Health Care Compliance, Johnson & Johnson, Founding Co-chair, Asia Pacific Pharma Compliance Congress, London, UK Andrew Martin Principal and Head of Corporate & Securities, Baker & McKenzie, Wong & Leow, Singapore Timothy J. McGuire, MBA Director, Global HCP Transparency Reporting, Eli Lilly and Company, Indianapolis, IN Alison Parkes, PhD Vice President Compliance Emerging Markets and APAC, Smith & Nephew, Singapore Kent Phillips Partner, Hogan Lovells Lee & Lee, Singapore Redentor Romero, JD Associate Director, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel, AstraZeneca, Singapore Yee Chung Seck, Esq. Partner and Lead, Pharmaceutical and Healthcare Practices, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam Sandeep Seth Compliance Director, India, Pfizer; Former Director, Compliance, MSD Pharmaceuticals Pvt. Ltd., Mumbai, India Clarissa Shen, MBA Vice President, Head of Ethics and Business Integrity, Sanofi Group - China; Former Associate Compliance Director, Eli Lilly Asia Inc.; Former Acting Compliance Head, BMS China, Shanghai, China Carol Shi Compliance Director, Asia Area and ANZ, AstraZeneca, Singapore Sabina Sudan, LLB, LLM ECLS-Consults (Ethics / Compliance / Legal / Sustainability), Legal/International Compliance and Risk Management Professional, , Singapore and Delhi, India Belinda Tan Partner, Fraud Investigations & Dispute Resolutions, EY, Singapore Boon Heon Tan, MSE Managing Director, South East Asia and Korea, UCB, Hong Kong, China Yuet Ming Tham, JD Partner, Sidley Austin LLP; Former Asia Pacific Regional Compliance Director, Pfizer; Former Deputy Public Prosecutor, Singapore, Hong Kong Albert van Maaren, MSc Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore Jonathan Shun Wah, PCLL Regional Compliance Director, Pfizer, Hong Kong Mark Wanda, JD Executive Director, Anti-Bribery/Anti-Corruption Compliance, Astellas US LLC, Former Sr. VP, Legal Affairs and GC, Sunovion, Former Sr. VP and Deputy GC, Sepracor, Chicago, IL, USA Chae Sing Wong Compliance Director, Asia, ANZ and Japan, Shire (Baxalta), Former Compliance Director Asia Area, AstraZeneca, Singapore Sow Wei Wong Legal Counsel Research and Development Centre, at Takeda Global (Asia) Pte Ltd, Former Senior Compliance Counsel, Allergan, Singapore Vivian W. Wu, LLB, LLM Partner, Baker & McKenzie, Beijing, China Jooha Yang Regional Compliance Manager, Roche Pharma Asia Pacific, Singapore Qi (Aaron) Yao, MA Compliance Manager, Cordis, Former Associate Manager, Compliance, Roche, Shanghai, China Riza Faith Ybanez, LLB Legal and Compliance Head - Oncology Asia Pacific, South Africa, Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore Mike Zhao Head, Compliance China, UCB Pharma, Shanghai, China

The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.

The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

• Accounting Professionals: Approved for up to 18.0 NASBE CPE credits.
• Compliance Professionals: Approved for 24 Compliance Certification Board CCB credits.
• Attorneys: Pending approval for Pennsylvania MCLE Credit.